rethinkTHC Search
Menu
Study breakdown

Cannabis Was the Most Commonly Detected Drug in Swiss Emergency Department Drug Toxicity Cases

ObservationalModerate evidence
The takeaway

Among over 50,000 emergency department visits in Basel, Switzerland, 210 were related to recreational drug toxicity, with cannabis detected in 33% of cases, making it the most commonly identified substance.

Read this if you want to understand how often cannabis contributes to emergency department visits compared to other recreational drugs.

Cannabis detected in 33% of drug-related ER cases, the most of any substance

What the researchers found

Over one year at a Swiss university hospital, researchers systematically tracked every emergency department visit related to recreational drug toxicity. Of 50,624 total ER visits, 210 (0.4%) were directly drug-related.

Cannabis was the most commonly detected substance at 33%, followed by cocaine at 27% and opioids at 19%. The typical patient was male (73%) with a mean age of 33 years.

The most frequent symptoms across all drug presentations were tachycardia (28%), anxiety (23%), nausea/vomiting (18%), and agitation (17%). Severe complications included two deaths, two heart attacks, 13 seizure cases, and 6 psychosis cases. Most patients (76%) were discharged home, while 10% required intensive care.

Notably, despite widespread concern about novel psychoactive substances (NPS), only 2 of 210 cases involved NPS, suggesting classic drugs remain far more clinically significant.

Why it matters

This study provides a reality check on drug-related emergency presentations. While NPS receive enormous media attention, cannabis and cocaine remain responsible for the vast majority of acute drug toxicity cases in clinical practice.

The numbers in context

210 drug-related cases out of 50,624 ER visits (0.4%). Cannabis: 33% of analytically confirmed cases. Cocaine: 27%. Opioids: 19%. Mean age: 33 years. 73% male. 76% discharged home. 10% ICU admission. Only 2 NPS cases.

How the study worked

Prospective case series of all emergency department presentations at the University Hospital of Basel, Switzerland, from October 2014 to September 2015 with acute toxicity from recreational drug use. Analytical confirmation using immunoassays and LC-MS/MS capable of detecting novel psychoactive substances.

What this study cannot tell us

Single center in one Swiss city. Self-reported drug use may be inaccurate. Not all patients received analytical confirmation. Cannabis detection may overrepresent its role in toxicity due to its long detection window. Polysubstance use was common.

How to read the evidence

Systematic prospective data collection with analytical confirmation. Strong methodology for a single-center study.

When this study was published

Published in 2016 using 2014-2015 data. Drug use patterns and NPS availability have continued to evolve.

The bigger picture

This systematic data collection provides a snapshot of real-world drug toxicity patterns in a Western European city. The dominance of cannabis among detected substances likely reflects its high prevalence of use rather than exceptional toxicity, as most cannabis-related presentations were of moderate severity.

Questions still open

  • What proportion of cannabis-related ER visits are due to anxiety/panic versus actual toxicity? Would these patterns differ in countries with legal cannabis? How do synthetic cannabinoid emergency presentations compare in countries where they are more prevalent?

Common questions

How common are cannabis-related emergency visits?
In this Swiss hospital, cannabis was involved in about a third of all drug-related ER visits, making it the most commonly detected substance. However, drug-related visits overall were only 0.4% of all ER traffic.
Are synthetic cannabinoids causing a lot of emergencies?
No. Despite media attention, only 2 of 210 drug-related ER cases involved novel psychoactive substances. Classic drugs like cannabis, cocaine, and opioids accounted for the vast majority.

Read the original research

Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.

BMC pharmacology & toxicology, 17(1), 25

Citation

Liakoni, Evangelia; Dolder, Patrick C; Rentsch, Katharina M; Liechti, Matthias E. (2016). Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.. BMC pharmacology & toxicology, 17(1), 25. https://doi.org/10.1186/s40360-016-0068-7

Explore the wider topic